--- Chain 6 for Question 102 ---
Status: USED_FOR_VOTING
Finish Reason (Model): stop
Extracted Answer: D
Prompt Tokens (Usage): 439
Completion Tokens (Usage): 4584
Reasoning Tokens (Counted): 3977
Non-Reasoning Tokens (Counted): 605
Total Tokens (Usage): N/A

--- Reasoning Content ---
Okay, so I've got this pretty detailed question about molecular biology techniques, specifically involving gene constructs, expression, and some microscopy results. Let me try to unpack this step by step.

The question is about why a green signal isn't observed under the confocal microscope after crossing mice with a certain construct. The setup involves a bicistronic lox-Cre vector, which I think means it has two ORFs in one vector. The vector has the ligand ORF at the 5' end, followed by mCherry, and the receptor ORF at the 3' end, followed by eGFP. 

So, the ligand is under the CBA promoter. CBA is a strong promoter, I think it's the cytomegalovirus promoter, which is constitutive and strong. The receptor is after an IRES element, which is a way to have two genes expressed from a single vector. IRES allows internal ribosome entry, so the second gene can be translated without the need for a second promoter. 

Between the ligand and mCherry, there's a loxP-stop-loxP cassette. And between the receptor and eGFP, there's a lox2272-stop-lox2272 cassette. I remember that loxP sites are recognition sites for Cre recombinase. So, if Cre is present, it can recombine these sites and remove the stop cassette, allowing the downstream genes to be expressed.

In the experiment, the person made a mouse model that's homozygous for this construct. Then they crossed it with SOX10-Cre hemizygous mice. SOX10 is a transcription factor important in neural crest development, I think. So the Cre is under the control of SOX10, meaning it's active in neural crest cells. So the idea is that in the offspring, Cre would be expressed in neural crest-derived cells, recombining the lox sites and allowing the ligand and receptor to be expressed.

But when they looked under the confocal, they didn't see any green signal. The eGFP is on the receptor construct, so if the receptor is expressed and eGFP is correctly tagged, they should see green fluorescence where the receptor is expressed.

Wait, but why no green? Let's think about the vector setup. The bicistronic construct has the ligand and receptor each in their own ORFs, with their own stop cassettes. The ligand is at 5' with mCherry, and the receptor at 3' with eGFP.

In a normal setup without Cre, the stop cassettes would prevent expression of the downstream genes. So without Cre, the ligand would be expressed (since it's under a strong promoter) but the mCherry would be after a stop. So the ligand would be expressed as a fusion to mCherry? Or is the mCherry a separate reporter? Hmm, maybe the ligand ORF is under the CBA promoter, and the mCherry is in frame? Or perhaps the ligand is fused to mCherry? Not sure, but perhaps that's not the main issue.

When Cre is introduced (like in the SOX10-Cre mice), the Cre should recognize the lox sites. The ligand's stop cassette is between ligand ORF and mCherry, so if Cre recombines loxP sites, it would excise the stop, allowing mCherry to be expressed along with the ligand. Similarly, for the receptor, the stop cassette is between receptor and eGFP. So Cre would recombine the lox2272 sites, excising the stop, allowing eGFP to be expressed when the receptor is expressed.

Wait, but loxP and lox2272 are different sites. Lox2272 is a variant of loxP that is more efficiently recognized by Cre. So, in the vector, the ligand has a loxP site on either side of the stop, and the receptor has a lox2272 site on either side. So when Cre is present, it would recombine the loxP sites in the ligand region, and the lox2272 sites in the receptor region.

So, in the offspring, the Cre should be active in neural crest cells, leading to recombination. So the ligand and mCherry would be expressed (if in the same cell), and the receptor and eGFP would be expressed in the same cell.

But in the experiment, the mouse is homozygous for the construct. Wait, noâ€”the construct is a lox-Cre vector, but when you cross with SOX10-Cre, the Cre is provided by the other parent. Wait, the mice were homozygous for the construct, but the construct itself doesn't have Cre, right? Because the Cre is under the SOX10 promoter. So the construct has the loxP and lox2272 sites, but the Cre comes from the SOX10-Cre mice.

So when the offspring are born, in cells where SOX10 is expressed (like neural crest cells), the Cre would be active, leading to recombination. So, in the neural crest cells, the stop cassettes should be excised, allowing the ligand and receptor to be expressed, along with their respective fluorescent proteins.

But in the confocal, no green signal. That suggests that the receptor and eGFP are not being expressed. Or perhaps the eGFP is not being properly expressed, maybe due to a frame issue.

Looking at the options, option D says the receptor and eGFP are not in frame. If the ORF for the receptor is not in frame with the eGFP, then the eGFP wouldn't be expressed. But wait, the stop cassette is between the receptor and eGFP. So if the stop is in frame, then the eGFP would not be expressed unless the stop is removed. But if the receptor and eGFP are in the same frame, then after the stop is removed, the receptor would be translated along with eGFP as a tag.

Wait, but the construct is set up so that the receptor ORF is followed by a stop cassette and then eGFP. So the stop is between them. If the stop is removed, the eGFP should be in frame with the receptor. So, if the eGFP is not expressed, perhaps the stop wasn't correctly excised, or the expression is not happening.

But why would the stop not be excised? Well, the Cre might not have been active. But the mice were crossed to SOX10-Cre, so SOX10 is expressed in neural crest cells, which should activate Cre. Unless the Cre isn't working properly, but that's probably not the case.

Alternatively, maybe the IRES isn't working. The receptor is under the control of the IRES element, so perhaps the IRES isn't efficiently driving the expression of the receptor. But IRES typically allows for internal initiation, so if the first ORF (ligand) is being translated, the IRES would allow the ribosome to switch and translate the receptor.

Wait, but in the vector, the ligand is under the CBA promoter, and then the receptor is under the IRES. So, if the ligand is being expressed, the IRES would drive the receptor expression. But if the construct is in the opposite orientation, or the IRES is not functional, then the receptor wouldn't be expressed.

Option C says the enhancer for ligand and receptor expression is missing. But the ligand is under a strong promoter (CBA) and the receptor is under an IRES, which is a regulatory element. So the enhancer might not be the issue.

Option A says ligand and receptor are in a paracrine relationship. Paracrine means they act on nearby cells. But I'm not sure how that relates to the expression of the eGFP. Maybe the ligand is secreted, and the receptor is on the cell surface. But that doesn't directly explain why the eGFP isn't showing up.

Option B says the receptor-eGFP construct is stuck in the Golgi. That would mean the protein isn't reaching the cell surface, so eGFP wouldn't fluoresce. But why would it be stuck in the Golgi? Maybe if the construct has a signal peptide or some retention signal. But according to the question, the receptor is a transmembrane protein, which typically goes to the cell membrane. So if the eGFP is part of the receptor construct, perhaps it's being properly trafficked, but maybe not.

Wait, the eGFP is at the C-terminus of the receptor. So if the receptor is correctly processed, eGFP should be on the cell surface, right? So if the eGFP isn't showing up, maybe the receptor isn't expressed, or the eGFP isn't being made.

Wait, but in the vector, the eGFP is after the stop cassette. So, upon Cre recombination, the stop is removed, and the eGFP should be expressed in frame with the receptor. So if the eGFP isn't showing up, perhaps the stop wasn't removed, or the frames don't match.

Wait, the stop cassettes are loxP-stop-loxP and lox2272-stop-lox2272. So, when Cre is present, it should remove the stop cassettes. For the ligand and mCherry, the stop is between them, so removing it would allow both to be expressed. Similarly for the receptor and eGFP.

But if the lox2272 sites are not correctly recognized by the Cre, perhaps the stop isn't excised. But the Cre is the same in the vector, so maybe the variant doesn't matter. Alternatively, perhaps the vector's lox2272 sites aren't compatible with the Cre used, but that's probably a stretch.

Alternatively, perhaps the IRES element isn't allowing the receptor to be expressed, so even with the stop cassette removed, the receptor isn't made. But IRES is supposed to drive expression even after the first ORF is translated. So if the ligand is expressed, the receptor should be, too.

Wait, maybe the problem is that the eGFP is not in frame. Let me think about the vector structure. The ligand ORF is at 5', followed by a stop cassette, then mCherry. The receptor ORF is at 3', preceded by an IRES, but after the stop cassette, which uses lox2272. So, the sequence is: CBA promoter -> ligand ORF -> loxP-stop-loxP -> mCherry. Then, IRES -> receptor ORF -> lox2272-stop-lox2272 -> eGFP.

When Cre is present, the loxP sites (for the ligand) are recombined, so the stop is removed, allowing mCherry to be expressed. Similarly, the lox2272 sites around the receptor's stop cassette are recombined, removing the stop and allowing eGFP to be expressed.

So, in the mouse, after Cre recombination, the ligand and mCherry should be expressed, and the receptor and eGFP should be expressed.

But in the Western blot, they checked the expression after transfecting the plasmid into astrocytes. They used antibodies against the overexpressed proteins. So perhaps the construct was expressed correctly in vitro, but not in the transgenic mice.

But when the mouse is crossed to SOX10-Cre, the Cre is expressed in neural crest cells. So in those cells, the ligand and receptor should be expressed, along with their tags.

But in the confocal, no green. So the eGFP isn't expressed. Why?

Option D suggests that the receptor and eGFP are not in frame. That would mean that when the stop is removed, the eGFP is not properly in frame, so it's not expressed. That could be a problem. If the stop cassette was in frame, then removing it would result in a frameshift, but if it's between the receptor and eGFP, perhaps the reading frame is maintained.

Wait, the stop cassette is between the receptor and eGFP. The stop is in frame, so when the stop is excised, the eGFP would be in frame with the receptor. But if the eGFP is in the same frame, then the entire open reading frame would include both the receptor and eGFP. So the eGFP would be a C-terminal tag on the receptor. So if the frame is correct, eGFP should be expressed.

But if the frame is incorrect, perhaps due to the vector setup, then the eGFP won't be expressed. For example, if the stop cassette is in frame, but the eGFP is not, then upon removal, the eGFP would not be in frame and thus not expressed.

Alternatively, perhaps the eGFP is not correctly cloned in frame with the receptor. Maybe the cloning introduced a frameshift, so the eGFP is not in the same reading frame as the receptor. In that case, the eGFP wouldn't be expressed because the stop codon would terminate translation early.

But the question says that the antibodies were raised against the overexpressed proteins. So in the Western blot, after transfection, they would have detected the proteinsâ€”so perhaps the in vitro expression was correct, but in vivo, the frame is wrong. That seems unlikely because the construct would have been the same in both cases.

Wait, but in the mouse, the construct is in the genomic DNA. If the construct is homozygous, perhaps the copy number affects expression, but that's a stretch.

Another angle: perhaps the IRES isn't working correctly. The receptor is under the control of the IRES, so if the IRES isn't functional, the receptor wouldn't be expressed even if the stop is removed. But IRES is usually functional, so that's possible but perhaps not the most likely reason.

Alternatively, maybe the expression of the ligand and receptor is in a paracrine manner. So the ligand is secreted and acts on neighboring cells. So the eGFP (on the receptor) would be expressed in other cells, not in the same cells where Cre was active. But the Western blot would probably still show expression in the lysate, so the antibody would pick it up.

Wait, but the question is about the confocal, which looks at live cells or fixed cells where the eGFP is expressed. If the ligand and receptor are in a paracrine relationship, perhaps the ligand is produced by some cells, and the receptor is in others, but that doesn't directly explain why the eGFP isn't expressed.

So, perhaps the problem is that the eGFP is not correctly in frame. So option D is the best fit. Alternatively, perhaps the Cre wasn't active, but the question states that the mice were crossed to SOX10-Cre, which should have Cre active in the neural crest.

Wait, another thought: the vector is bicistronic, so each of the two ORFs (ligand and receptor) is under separate control. The ligand has its own promoter (CBA), and the receptor is under the IRES. So when Cre is active, both the ligand and receptor are expressed. But perhaps the IRES isn't working, so the receptor isn't expressed. But that's option C or something else.

Alternatively, perhaps the SOX10-Cre isn't active in the cells where the construct is expressed. Or perhaps the construct isn't properly integrated.

Wait, the mouse is homozygous for the construct. So perhaps the construct has two copies of the same thing. But in that case, the expression would be even more pronounced.

Wait, another possibility: the eGFP is under the control of the same promoter as the receptor, but in the construct, the eGFP is after the stop cassette. So if the stop isn't removed, eGFP isn't expressed. But the Western blot was done on transfected cells, so the construct must have been correctly processed in vitro, leading to expression of the eGFP. So in the transfected cells, the stop must have been removed, implying that Cre was active. So in the mouse, why isn't the eGFP expressed?

Wait, unless the Cre wasn't active in the cells where the construct is expressed. But the mice were crossed to SOX10-Cre, which should activate Cre in neural crest cells. So in those cells, Cre should be expressed and the stop cassettes should be removed.

But perhaps the issue is that the frame is wrong. So when the stop is removed, the eGFP isn't in frame, and thus isn't expressed. So the Western blot would not pick up the eGFP, but they used antibodies against the overexpressed proteins. Wait, but the question says that the antibodies were raised against the overexpressed proteins, so perhaps the eGFP is not part of the target. So the Western blot would show the presence of the ligand and receptor, but not eGFP.

Wait, no. Wait, the Western blot was to test the construct expression after plasmid transfection. So in the transfected astrocytes, they would express the constructs. If the Cre is not present in the transfected cells (since Cre was only in the mice crossed with SOX10-Cre), then the stop cassettes wouldn't be recombined. So the ligand would be expressed (since under a strong promoter), but the mCherry wouldn't because the stop is in place. Similarly, the receptor wouldn't be expressed because the IRES requires the first ORF to be translated. So in the transfected cells (without Cre), the ligand would be expressed, but the receptor wouldn't.

But in the question, the mouse is homozygous for the construct. So the construct is present in the genome. Then, when crossed with SOX10-Cre, the Cre would be active in neural crest cells, recombining the stop cassettes and allowing ligand and receptor expression.

But in the confocal, the eGFP isn't expressed. So, perhaps the stop wasn't recombined, so eGFP isn't made. But why? If the Cre is active, the stop should be recombined.

Another possibility: the eGFP is in the wrong reading frame after the stop is removed. So the eGFP isn't expressed. That would fit option D.

So, putting it all together, the most likely reason is that the receptor and eGFP are not in frame, so when the stop is removed, the eGFP isn't translated. Therefore, no green signal is observed.


--- Final Answer Content ---


The question involves a bicistronic lox-Cre vector expressing a ligand and receptor pair, with fluorescent protein tags (mCherry and eGFP) downstream of stop cassettes. The ligand is under the CBA promoter, and the receptor is under an IRES element. The stop cassettes are flanked by loxP and lox2272 sites, which are excised by Cre recombinase to allow expression of the downstream tags. The mouse model is homozygous for the construct and crossed with SOX10-Cre mice to activate Cre in neural crest cells, enabling ligand and receptor expression. However, no green signal (eGFP) is observed under the confocal microscope.

### Key Analysis:
1. **Vector Design and Cre Activity**:
   - The ligand and receptor are separated by stop cassettes. Cre recombinase, provided by SOX10-Cre mice, should excise these stop cassettes in neural crest cells, allowing expression of the ligand-mCherry and receptor-eGFP fusion proteins.
   - The absence of a green signal suggests that the receptor-eGFP fusion is not being expressed or detected.

2. **Potential Issues**:
   - **Option A (Paracrine Relationship)**: While the ligand-receptor pair may act in a paracrine manner, this does not explain the lack of eGFP expression in the confocal microscopy. Paracrine signaling would not prevent eGFP from being expressed in the cells where Cre is active.
   - **Option B (Receptor-eGFP Stuck in the Golgi)**: If the receptor-eGFP were retained in the Golgi, it would not reach the cell surface for detection. However, the receptor is a transmembrane protein, and eGFP is a cytosolic tag, making this explanation less likely.
   - **Option C (Missing Enhancer for Expression)**: The ligand is under the strong CBA promoter, and the receptor is under the IRES element, which should allow expression. There is no evidence that an enhancer is missing, making this explanation less plausible.
   - **Option D (Receptor and eGFP Not in Frame)**: The stop cassette between the receptor and eGFP must be excised in frame for eGFP to be expressed. If the stop cassette is not excised correctly or if the eGFP is not in frame with the receptor, eGFP would not be expressed. This is the most likely explanation, as improper framing would prevent translation of eGFP even if the stop cassette is excised.

3. **Conclusion**:
   The absence of the green signal is most likely due to the receptor and eGFP not being in the correct reading frame after excision of the stop cassette. This prevents eGFP from being expressed and detected under the confocal microscope.

Answer: D

--- Full Content ---
Okay, so I've got this pretty detailed question about molecular biology techniques, specifically involving gene constructs, expression, and some microscopy results. Let me try to unpack this step by step.

The question is about why a green signal isn't observed under the confocal microscope after crossing mice with a certain construct. The setup involves a bicistronic lox-Cre vector, which I think means it has two ORFs in one vector. The vector has the ligand ORF at the 5' end, followed by mCherry, and the receptor ORF at the 3' end, followed by eGFP. 

So, the ligand is under the CBA promoter. CBA is a strong promoter, I think it's the cytomegalovirus promoter, which is constitutive and strong. The receptor is after an IRES element, which is a way to have two genes expressed from a single vector. IRES allows internal ribosome entry, so the second gene can be translated without the need for a second promoter. 

Between the ligand and mCherry, there's a loxP-stop-loxP cassette. And between the receptor and eGFP, there's a lox2272-stop-lox2272 cassette. I remember that loxP sites are recognition sites for Cre recombinase. So, if Cre is present, it can recombine these sites and remove the stop cassette, allowing the downstream genes to be expressed.

In the experiment, the person made a mouse model that's homozygous for this construct. Then they crossed it with SOX10-Cre hemizygous mice. SOX10 is a transcription factor important in neural crest development, I think. So the Cre is under the control of SOX10, meaning it's active in neural crest cells. So the idea is that in the offspring, Cre would be expressed in neural crest-derived cells, recombining the lox sites and allowing the ligand and receptor to be expressed.

But when they looked under the confocal, they didn't see any green signal. The eGFP is on the receptor construct, so if the receptor is expressed and eGFP is correctly tagged, they should see green fluorescence where the receptor is expressed.

Wait, but why no green? Let's think about the vector setup. The bicistronic construct has the ligand and receptor each in their own ORFs, with their own stop cassettes. The ligand is at 5' with mCherry, and the receptor at 3' with eGFP.

In a normal setup without Cre, the stop cassettes would prevent expression of the downstream genes. So without Cre, the ligand would be expressed (since it's under a strong promoter) but the mCherry would be after a stop. So the ligand would be expressed as a fusion to mCherry? Or is the mCherry a separate reporter? Hmm, maybe the ligand ORF is under the CBA promoter, and the mCherry is in frame? Or perhaps the ligand is fused to mCherry? Not sure, but perhaps that's not the main issue.

When Cre is introduced (like in the SOX10-Cre mice), the Cre should recognize the lox sites. The ligand's stop cassette is between ligand ORF and mCherry, so if Cre recombines loxP sites, it would excise the stop, allowing mCherry to be expressed along with the ligand. Similarly, for the receptor, the stop cassette is between receptor and eGFP. So Cre would recombine the lox2272 sites, excising the stop, allowing eGFP to be expressed when the receptor is expressed.

Wait, but loxP and lox2272 are different sites. Lox2272 is a variant of loxP that is more efficiently recognized by Cre. So, in the vector, the ligand has a loxP site on either side of the stop, and the receptor has a lox2272 site on either side. So when Cre is present, it would recombine the loxP sites in the ligand region, and the lox2272 sites in the receptor region.

So, in the offspring, the Cre should be active in neural crest cells, leading to recombination. So the ligand and mCherry would be expressed (if in the same cell), and the receptor and eGFP would be expressed in the same cell.

But in the experiment, the mouse is homozygous for the construct. Wait, noâ€”the construct is a lox-Cre vector, but when you cross with SOX10-Cre, the Cre is provided by the other parent. Wait, the mice were homozygous for the construct, but the construct itself doesn't have Cre, right? Because the Cre is under the SOX10 promoter. So the construct has the loxP and lox2272 sites, but the Cre comes from the SOX10-Cre mice.

So when the offspring are born, in cells where SOX10 is expressed (like neural crest cells), the Cre would be active, leading to recombination. So, in the neural crest cells, the stop cassettes should be excised, allowing the ligand and receptor to be expressed, along with their respective fluorescent proteins.

But in the confocal, no green signal. That suggests that the receptor and eGFP are not being expressed. Or perhaps the eGFP is not being properly expressed, maybe due to a frame issue.

Looking at the options, option D says the receptor and eGFP are not in frame. If the ORF for the receptor is not in frame with the eGFP, then the eGFP wouldn't be expressed. But wait, the stop cassette is between the receptor and eGFP. So if the stop is in frame, then the eGFP would not be expressed unless the stop is removed. But if the receptor and eGFP are in the same frame, then after the stop is removed, the receptor would be translated along with eGFP as a tag.

Wait, but the construct is set up so that the receptor ORF is followed by a stop cassette and then eGFP. So the stop is between them. If the stop is removed, the eGFP should be in frame with the receptor. So, if the eGFP is not expressed, perhaps the stop wasn't correctly excised, or the expression is not happening.

But why would the stop not be excised? Well, the Cre might not have been active. But the mice were crossed to SOX10-Cre, so SOX10 is expressed in neural crest cells, which should activate Cre. Unless the Cre isn't working properly, but that's probably not the case.

Alternatively, maybe the IRES isn't working. The receptor is under the control of the IRES element, so perhaps the IRES isn't efficiently driving the expression of the receptor. But IRES typically allows for internal initiation, so if the first ORF (ligand) is being translated, the IRES would allow the ribosome to switch and translate the receptor.

Wait, but in the vector, the ligand is under the CBA promoter, and then the receptor is under the IRES. So, if the ligand is being expressed, the IRES would drive the receptor expression. But if the construct is in the opposite orientation, or the IRES is not functional, then the receptor wouldn't be expressed.

Option C says the enhancer for ligand and receptor expression is missing. But the ligand is under a strong promoter (CBA) and the receptor is under an IRES, which is a regulatory element. So the enhancer might not be the issue.

Option A says ligand and receptor are in a paracrine relationship. Paracrine means they act on nearby cells. But I'm not sure how that relates to the expression of the eGFP. Maybe the ligand is secreted, and the receptor is on the cell surface. But that doesn't directly explain why the eGFP isn't showing up.

Option B says the receptor-eGFP construct is stuck in the Golgi. That would mean the protein isn't reaching the cell surface, so eGFP wouldn't fluoresce. But why would it be stuck in the Golgi? Maybe if the construct has a signal peptide or some retention signal. But according to the question, the receptor is a transmembrane protein, which typically goes to the cell membrane. So if the eGFP is part of the receptor construct, perhaps it's being properly trafficked, but maybe not.

Wait, the eGFP is at the C-terminus of the receptor. So if the receptor is correctly processed, eGFP should be on the cell surface, right? So if the eGFP isn't showing up, maybe the receptor isn't expressed, or the eGFP isn't being made.

Wait, but in the vector, the eGFP is after the stop cassette. So, upon Cre recombination, the stop is removed, and the eGFP should be expressed in frame with the receptor. So if the eGFP isn't showing up, perhaps the stop wasn't removed, or the frames don't match.

Wait, the stop cassettes are loxP-stop-loxP and lox2272-stop-lox2272. So, when Cre is present, it should remove the stop cassettes. For the ligand and mCherry, the stop is between them, so removing it would allow both to be expressed. Similarly for the receptor and eGFP.

But if the lox2272 sites are not correctly recognized by the Cre, perhaps the stop isn't excised. But the Cre is the same in the vector, so maybe the variant doesn't matter. Alternatively, perhaps the vector's lox2272 sites aren't compatible with the Cre used, but that's probably a stretch.

Alternatively, perhaps the IRES element isn't allowing the receptor to be expressed, so even with the stop cassette removed, the receptor isn't made. But IRES is supposed to drive expression even after the first ORF is translated. So if the ligand is expressed, the receptor should be, too.

Wait, maybe the problem is that the eGFP is not in frame. Let me think about the vector structure. The ligand ORF is at 5', followed by a stop cassette, then mCherry. The receptor ORF is at 3', preceded by an IRES, but after the stop cassette, which uses lox2272. So, the sequence is: CBA promoter -> ligand ORF -> loxP-stop-loxP -> mCherry. Then, IRES -> receptor ORF -> lox2272-stop-lox2272 -> eGFP.

When Cre is present, the loxP sites (for the ligand) are recombined, so the stop is removed, allowing mCherry to be expressed. Similarly, the lox2272 sites around the receptor's stop cassette are recombined, removing the stop and allowing eGFP to be expressed.

So, in the mouse, after Cre recombination, the ligand and mCherry should be expressed, and the receptor and eGFP should be expressed.

But in the Western blot, they checked the expression after transfecting the plasmid into astrocytes. They used antibodies against the overexpressed proteins. So perhaps the construct was expressed correctly in vitro, but not in the transgenic mice.

But when the mouse is crossed to SOX10-Cre, the Cre is expressed in neural crest cells. So in those cells, the ligand and receptor should be expressed, along with their tags.

But in the confocal, no green. So the eGFP isn't expressed. Why?

Option D suggests that the receptor and eGFP are not in frame. That would mean that when the stop is removed, the eGFP is not properly in frame, so it's not expressed. That could be a problem. If the stop cassette was in frame, then removing it would result in a frameshift, but if it's between the receptor and eGFP, perhaps the reading frame is maintained.

Wait, the stop cassette is between the receptor and eGFP. The stop is in frame, so when the stop is excised, the eGFP would be in frame with the receptor. But if the eGFP is in the same frame, then the entire open reading frame would include both the receptor and eGFP. So the eGFP would be a C-terminal tag on the receptor. So if the frame is correct, eGFP should be expressed.

But if the frame is incorrect, perhaps due to the vector setup, then the eGFP won't be expressed. For example, if the stop cassette is in frame, but the eGFP is not, then upon removal, the eGFP would not be in frame and thus not expressed.

Alternatively, perhaps the eGFP is not correctly cloned in frame with the receptor. Maybe the cloning introduced a frameshift, so the eGFP is not in the same reading frame as the receptor. In that case, the eGFP wouldn't be expressed because the stop codon would terminate translation early.

But the question says that the antibodies were raised against the overexpressed proteins. So in the Western blot, after transfection, they would have detected the proteinsâ€”so perhaps the in vitro expression was correct, but in vivo, the frame is wrong. That seems unlikely because the construct would have been the same in both cases.

Wait, but in the mouse, the construct is in the genomic DNA. If the construct is homozygous, perhaps the copy number affects expression, but that's a stretch.

Another angle: perhaps the IRES isn't working correctly. The receptor is under the control of the IRES, so if the IRES isn't functional, the receptor wouldn't be expressed even if the stop is removed. But IRES is usually functional, so that's possible but perhaps not the most likely reason.

Alternatively, maybe the expression of the ligand and receptor is in a paracrine manner. So the ligand is secreted and acts on neighboring cells. So the eGFP (on the receptor) would be expressed in other cells, not in the same cells where Cre was active. But the Western blot would probably still show expression in the lysate, so the antibody would pick it up.

Wait, but the question is about the confocal, which looks at live cells or fixed cells where the eGFP is expressed. If the ligand and receptor are in a paracrine relationship, perhaps the ligand is produced by some cells, and the receptor is in others, but that doesn't directly explain why the eGFP isn't expressed.

So, perhaps the problem is that the eGFP is not correctly in frame. So option D is the best fit. Alternatively, perhaps the Cre wasn't active, but the question states that the mice were crossed to SOX10-Cre, which should have Cre active in the neural crest.

Wait, another thought: the vector is bicistronic, so each of the two ORFs (ligand and receptor) is under separate control. The ligand has its own promoter (CBA), and the receptor is under the IRES. So when Cre is active, both the ligand and receptor are expressed. But perhaps the IRES isn't working, so the receptor isn't expressed. But that's option C or something else.

Alternatively, perhaps the SOX10-Cre isn't active in the cells where the construct is expressed. Or perhaps the construct isn't properly integrated.

Wait, the mouse is homozygous for the construct. So perhaps the construct has two copies of the same thing. But in that case, the expression would be even more pronounced.

Wait, another possibility: the eGFP is under the control of the same promoter as the receptor, but in the construct, the eGFP is after the stop cassette. So if the stop isn't removed, eGFP isn't expressed. But the Western blot was done on transfected cells, so the construct must have been correctly processed in vitro, leading to expression of the eGFP. So in the transfected cells, the stop must have been removed, implying that Cre was active. So in the mouse, why isn't the eGFP expressed?

Wait, unless the Cre wasn't active in the cells where the construct is expressed. But the mice were crossed to SOX10-Cre, which should activate Cre in neural crest cells. So in those cells, Cre should be expressed and the stop cassettes should be removed.

But perhaps the issue is that the frame is wrong. So when the stop is removed, the eGFP isn't in frame, and thus isn't expressed. So the Western blot would not pick up the eGFP, but they used antibodies against the overexpressed proteins. Wait, but the question says that the antibodies were raised against the overexpressed proteins, so perhaps the eGFP is not part of the target. So the Western blot would show the presence of the ligand and receptor, but not eGFP.

Wait, no. Wait, the Western blot was to test the construct expression after plasmid transfection. So in the transfected astrocytes, they would express the constructs. If the Cre is not present in the transfected cells (since Cre was only in the mice crossed with SOX10-Cre), then the stop cassettes wouldn't be recombined. So the ligand would be expressed (since under a strong promoter), but the mCherry wouldn't because the stop is in place. Similarly, the receptor wouldn't be expressed because the IRES requires the first ORF to be translated. So in the transfected cells (without Cre), the ligand would be expressed, but the receptor wouldn't.

But in the question, the mouse is homozygous for the construct. So the construct is present in the genome. Then, when crossed with SOX10-Cre, the Cre would be active in neural crest cells, recombining the stop cassettes and allowing ligand and receptor expression.

But in the confocal, the eGFP isn't expressed. So, perhaps the stop wasn't recombined, so eGFP isn't made. But why? If the Cre is active, the stop should be recombined.

Another possibility: the eGFP is in the wrong reading frame after the stop is removed. So the eGFP isn't expressed. That would fit option D.

So, putting it all together, the most likely reason is that the receptor and eGFP are not in frame, so when the stop is removed, the eGFP isn't translated. Therefore, no green signal is observed.


The question involves a bicistronic lox-Cre vector expressing a ligand and receptor pair, with fluorescent protein tags (mCherry and eGFP) downstream of stop cassettes. The ligand is under the CBA promoter, and the receptor is under an IRES element. The stop cassettes are flanked by loxP and lox2272 sites, which are excised by Cre recombinase to allow expression of the downstream tags. The mouse model is homozygous for the construct and crossed with SOX10-Cre mice to activate Cre in neural crest cells, enabling ligand and receptor expression. However, no green signal (eGFP) is observed under the confocal microscope.

### Key Analysis:
1. **Vector Design and Cre Activity**:
   - The ligand and receptor are separated by stop cassettes. Cre recombinase, provided by SOX10-Cre mice, should excise these stop cassettes in neural crest cells, allowing expression of the ligand-mCherry and receptor-eGFP fusion proteins.
   - The absence of a green signal suggests that the receptor-eGFP fusion is not being expressed or detected.

2. **Potential Issues**:
   - **Option A (Paracrine Relationship)**: While the ligand-receptor pair may act in a paracrine manner, this does not explain the lack of eGFP expression in the confocal microscopy. Paracrine signaling would not prevent eGFP from being expressed in the cells where Cre is active.
   - **Option B (Receptor-eGFP Stuck in the Golgi)**: If the receptor-eGFP were retained in the Golgi, it would not reach the cell surface for detection. However, the receptor is a transmembrane protein, and eGFP is a cytosolic tag, making this explanation less likely.
   - **Option C (Missing Enhancer for Expression)**: The ligand is under the strong CBA promoter, and the receptor is under the IRES element, which should allow expression. There is no evidence that an enhancer is missing, making this explanation less plausible.
   - **Option D (Receptor and eGFP Not in Frame)**: The stop cassette between the receptor and eGFP must be excised in frame for eGFP to be expressed. If the stop cassette is not excised correctly or if the eGFP is not in frame with the receptor, eGFP would not be expressed. This is the most likely explanation, as improper framing would prevent translation of eGFP even if the stop cassette is excised.

3. **Conclusion**:
   The absence of the green signal is most likely due to the receptor and eGFP not being in the correct reading frame after excision of the stop cassette. This prevents eGFP from being expressed and detected under the confocal microscope.

Answer: D